Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/11000/31437

Calculating individualized glycaemic targets using an algorithm based on expert worldwide diabetologists: Implications in real‐ life clinical practice


Vista previa

Ver/Abrir:
 2018 Calculating individualized (1) (1).pdf

345,82 kB
Adobe PDF
Compartir:
Título :
Calculating individualized glycaemic targets using an algorithm based on expert worldwide diabetologists: Implications in real‐ life clinical practice
Autor :
Alvarez‐Guisasola, Fernando
Cebrián‐Cuenca, Ana M.
Cos, Xavier
Ruiz‐Quintero, Manuel
Millaruelo, Jose M.
Cahn, Avivit
Raz, Itamar
Orozco‐Beltrán, Domingo
Editor :
WILEY
Departamento:
Departamentos de la UMH::Medicina Clínica
Fecha de publicación:
2017
URI :
https://hdl.handle.net/11000/31437
Resumen :
Background: The aim of this study was to assess the clinical implications of calculating an individualized HbA1c target using a recently published algorithm in a real‐life clinical setting. Methods: General practitioners (GPs) from the Spanish Society of Family Medicine Diabetes Expert Group were invited to participate in the study. Each GP selected a random sample of patients with diabetes from his or her practice and submitted their demographic and clinical data for analysis. Individualized glycaemic targets were calculated according to the algorithm. Predictors of good glycaemic control were studied. The rate of patients attaining their individualized glycaemic target or the uniform target of HbA1c < 7.0% was calculated. Results: Forty GPs included 408 patients in the study. Of the 8 parameters included in the algorithm, “comorbidities,” “risk of hypoglycaemia from treatment,” and “diabetes duration” had the greatest impact on determining the individualized glycaemic target. Number of glucose‐ lowering agents and adherence were independently associated with glycaemic control. Overall, 60.5% of patients had good glycaemic control per individualized target, and 56.1% were well controlled per the uniform target of HbA1c < 7.0% (P = .20). However, 12.8% (23 of 246) of the patients with HbA1c ≥ 7.0% were adequately controlled per individualized target, and 2.6% (6 of 162) of the patients with HbA1c < 7.0% were uncontrolled since their individualized target was lower. Conclusions: In a real‐life clinical setting, applying individualized targets did not change the overall rate of patients with good glycaemic control yet led to reclassification of 7.1% (29 of 408) of the patients. More studies are needed to validate these results in different populations
Palabras clave/Materias:
community care
glycaemic control
survey research
type 2 diabetes
HbA1c target
Área de conocimiento :
CDU: Ciencias aplicadas: Medicina
Tipo documento :
application/pdf
Derechos de acceso:
info:eu-repo/semantics/openAccess
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
DOI :
https://doi.org/10.1002/dmrr.2976
Aparece en las colecciones:
Artículos Medicina Clínica



Creative Commons La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.